Jorge Arca-Suárez

Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

Miquel Àngel Sastre-Femenía, Almudena Fernández-Muñoz, María A. Gomis-Font et al. · The Lancet Regional Health - Europe · 2023 · 73 citations · Full text

Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group

Antonio Oliver, Estrella Rojo‐Molinero, Jorge Arca-Suárez et al. · Clinical Microbiology and Infection · 2023 · 73 citations · Full text

Molecular mechanisms driving the<i>in vivo</i>development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR<i>Pseudomonas aeruginosa</i>infections

Jorge Arca-Suárez, Cristina Lasarte-Monterrubio, Bruno-Kotska Rodiño-Janeiro et al. · Journal of Antimicrobial Chemotherapy · 2020 · 59 citations

Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant <i>Pseudomonas aeruginosa</i>

Cristina Lasarte-Monterrubio, Pablo A. Fraile-Ribot, Juan Carlos Vázquez-Ucha et al. · Journal of Antimicrobial Chemotherapy · 2022 · 49 citations

Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales

Juan Carlos Vázquez-Ucha, Alejandro Seoane-Estévez, Bruno K. Rodiño‐Janeiro et al. · Journal of Antimicrobial Chemotherapy · 2021 · 46 citations · Full text